A carregar...
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
Immunomodulatory and analgesic effects of dexamethasone are clinically well established, and this synthetic corticosteroid acts as an agonist of glucocorticoid receptors. Early results of the RECOVERY Trial from the United Kingdom and others suggest certain benefits of dexamethasone against COVID-19...
Na minha lista:
| Publicado no: | Per Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8186476/ https://ncbi.nlm.nih.gov/pubmed/34086487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme-2020-0183 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|